Use of immunocytochemical techniques in canine melanoma

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 49, Issue 4, 2002, Pages 198-202

  Hoinghaus R ^a   Mischke, R ^a   Hewicker Trautwein, M ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; MART1 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN S 100; TUMOR ANTIGEN; TUMOR PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPH NODE; MALE; MELANOMA; PATHOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MELANOMA; NEOPLASM PROTEINS; S100 PROTEINS;

EID: 0036559420     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0442.2002.00440.x     Document Type: Article

References (25)

1. Banerjee, S. S., and M Harns, 2000: Morphological and immunophenotyping variations in malignant melanoma. Histopathology 36, 387-402.
2. Berrington, A. J., K. Jimbow, and D. M. Haines, 1994: Immunohistochemical detection of melanoma-associated antigens on formalin-fixed, paraffin-embedded canine tumors Vet Pathol. 31, 455-461.
3. Busam, K. J., K. Iversen, K. A. Coplan, L. J Old, E. Stockert, Y. T. Chen, D. P. McGregor, and A. Jungbluth, 1998. Immunoreactivity for A103, an antibody to melan-A (MART-1), in adrenocortical and other steroid tumors. Am. J. Surg. Pathol. 22, 57-63.
4. Carbone, A , R Manconi, A. Poletti, and R Volpe, 1986: Significance of S-100 protein immunostaining in the immunohistological analysis of normal and neoplastic lymphoid tissues - an appraisal. Int. J. Biol. Markers 1, 57-66.
5. Chen, Y.-T., E Stockert, A. Jungbluth, S. Tsang, K. A. Coplan, M J. Scanlan, and L. J Old. 1996: Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc. Natl. Acad. Sci. USA 93, 5915-5919.
6. Cocchia, D., L. Lauriola, V. M. Stolfi, G. Tallini, and F. Michetti, 1983: S-100 antigen labels neoplastic cells in liposarcoma and cartilaginous tumours. Virchows Arch. A Pathol. Anat. Histopathol. 402, 139-145.
7. Drier, J. K., P. E. Swanson, D. L. Cherwitz, and M. R. Wick, 1987: S100 protein immunoreactivity in poorly differentiated carcinomas. Arch. Pathol. Lab. Med. 111, 447-452.
8. Fetsch, P. A., F. M. Marineola, A. Fillie, Y. M. Hijazi, D. E. Kleiner, and A. Abati, 1999: Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration. Cancer 87, 37-42.
9. Gupta, R. K , and S. Lallu, 1997: Cytodiagnosis of amelanotic metastatic malignant melanoma, an immunocytochemical study. Diagn. Cytopathol. 16, 238-241.
10. Jungbluth, A. A., K. J. Busam, W L. Gerald, E. Stockert, K. A. Coplan, K. Iversen, D P. McGregor. L. J. Old, and Y. T. Chen, 1998. A103: an anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am. J. Surg. Pathol. 22, 595-602.
11. Kahn, H. J., A. Marks, H. Thom, and R. Baumal, 1983: Role of antibody to S100 protein in diagnostic pathology. Am. J. Clin. Pathol. 79, 341-347.
12. Kindblom, L.-G., P. Lodding, L. Rosengren, J. Baudier, and K. Haglid, 1984: Detection of S100 labelled cells in melanocytic tumors. Acta Pathol. Microbiol. Immunol. Scand. Sect. A 92, 219-230.
13. Loeffler, H., and J. Rastetter, 1979: Atlas of clinical hematology. Springer-Verlag, Berlin.
14. Modiano, J. F., M. G. Ritt, and D. J Wojcieszyn, 1999: The molecular basis of canine melanoma: pathogenesis and trends in diagnosis and therapy. J. Vet. Intern. Med. 13, 163-174.
15. Moore, B. W., 1965: A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 19, 739-744.
16. Moulton, J. E., 1990: Tumours in Domestic Animals. 3rd edn. University of California Press, Berkley
17. Nakajima, T., S. Watanabe, Y. Sato, T. Kameya, and Y. Shimosato, 1982: An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am. J. Surg. Pathol. 6, 715-727.
18. Okajima, K., I. Honda, and T. Kitagawa, 1988: Immunohistochcmical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage. Cancer 61, 792-799.
19. Oliver, J L., and L. G. Wolfe, 1992: Antigen expression in canine tissues, recognized by a monoclonal antibody generated against canine melanoma cells. Am. J. Vet Res. 53, 123-128.
20. Orchard, G. E., 2000. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-a. tyrosinase and HMB 45 with NKIC3 and S100 protein in evaluation of benign naevi and malignant melanoma. Histochem. J. 32, 475-481.
21. Orosz, Z., 1999. Melan-A/MART-1 expression in various melanocytic lesions and non-melanocytic soft tissue tumours. Histopathology 34, 517-525.
22. Ramos-Vara, J. A., M. E. Beissenherz, M. A. Miller, G. C Johnson, L W Pace, A. Fard, and S. J. Kottler, 2000: Retrospective study of 338 canine oral melanomas with clinical, histologic and immunohistochemical review of 129 cases. Vet. Pathol. 37, 597-608.
23. Sandusky, G. E , W W. Carlton, and K. A. Wightman, 1987: Diagnostic immunohistochemistry of canine round cell tumors. Vet. Pathol. 24, 495-499.
24. Yager, J. A., D. W. Scott, and B. P. Wilcock, 1993: The skin and appendages. In: Jubb, K. V. F , P. C. Kennedy, and N. Palmer (eds), Pathology of Domestic Animals, 4th edn, Vol. 1. pp. 531-783. Academic Press, San Diego.
25. Yambe, H., Y. Ishii, K. Tabuchi, T. Isobe, and K. Kikuchi, 1984: Detection of S-100 protein in melanocytic and neurogenic cutaneous tumors. Arch. Dermatol. Res. 276, 160-164.